medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2023, Number 11

<< Back

Ginecol Obstet Mex 2023; 91 (11)

Buschke-Löwenstein tumor in pregnancy: A case report

Sotres GAI, Adame CJE

Language: Spanish
References: 26
Page: 861-867
PDF size: 267.21 Kb.


ABSTRACT

Background: Buschke-Löwenstein tumor, also called giant condyloma acuminatum, is a rare condition due to the human papillomavirus with an incidence of 0.01% and just 6 cases reported in pregnancy. There is no consensus on the treatment, although surgery has been the most reported.
Clinical case: A 14-year-old primigravid patient with a 21 weeks pregnancy who was admitted to the Emergency Department due to a perineal painful tumor which appeared 5 months before. On physical examination two irregular exophytic, cauliflower-like and ulcerated lesions of 20x10 cm of size each one with malodorous discharge were found on her perineal region suggestive of giant condyloma acuminatum. We decided to respect the tumor with tumor-free margin control and healing per second time. The pathology reports a giant condyloma acuminatum with tumor-free margin. The PCR analysis revealed human papillomavirus genotype 53. Complete epithelialization was noted at 12 weeks without complications noted.
Conclusion: Buschke-Löwenstein tumor is considered as a benign tumor, but it carries a risk of malignant transformation, and it can appear after treatment which makes important to strengthen the prevention and screening of human papillomavirus.


REFERENCES

  1. Prevención, detección, diagnóstico y tratamiento delesiones precursoras del cáncer de cuello uterino enprimer y segundo nivel de atención. Guía de Evidencias yRecomendaciones: Guía de Práctica clínica. 2018. http://cenetec-difusion.com/CMGPC/GPC-SS-146-18/ER.pdf

  2. Juárez-González K, Paredes-Cervantes V, Martínez-SalazarM, Gordillo-Rodríguez S, et al. Prevalencia del virus delpapiloma humano oncogénico en pacientes con lesión cervical.Rev Med Inst Mex Seguro Soc 2020; 58 (3): 243-249.https://doi.org/10.24875/RMIMSS.M20000027

  3. Malek-Mellouli M, Ben-Amara F, Fatnassi A, Reziga H. Giantcondyloma in pregnancy. Tunis Med 2013; 91 (6): 422-423.

  4. Illades-Aguiar B, Cortés-Malagón EM, Antonio-Véjar V,Zamudio-López N, et al. Cervical carcinoma in SouthernMexico: Human papillomavirus and cofactors. Cancer DetectPrev 2009; 32 (4): 300-307. https://doi.org/10.1016/j.cdp.2008.09.001

  5. Crespo R, Puig F, Lanzon A, Borell A. Buschke-Lowensteintumor and pregnancy: a case report. Eur J Gynaecol Oncol2007; 28 (4): 328-329.

  6. Garozzo G, Nuciforo G, Rocchi CM, Bonanno NM, et al.Büschke-Lowenstein tumour in pregnancy. Eur J ObstetGynecol Reprod Biol 2003; 111 (1): 88-90. https://doi.org/10.1016/s0301-2115(03)00112-x

  7. de Sanjosé S, Brotons M, Pavón MA. The natural historyof human papillomavirus infection. Best Pract Res ClinObstet Gynaecol 2018; 47: 2-13. https://doi.org/10.1016/j.bpobgyn.2017.08.015

  8. Riethmuller D, Buisson A, Thong-Vanh C, Istasse F, et al. Latumeur de Buschke Lowenstein chez la femme enceinte[Giant condyloma acuminatum in pregnancy]. GynecolObstet Fertil Senol 2022; 50 (2): 201-204. https://doi.org/10.1016/j.gofs.2021.08.001

  9. Cui T, Huang J, Lv B, Yao Q. Giant condyloma acuminatumin pregnancy: A case report. Dermatol Ther 2019; 32 (4):e12972. https://doi.org/10.1111/dth.12972

  10. Michiels I, Tjalma WA. The rapid development of a giantcondyloma acuminatum (Buschke-Löwenstein tumor)during pregnancy. Acta Obstet Gynecol Scand 2007; 86 (6):762-763. https://doi.org/10.1080/00016340600617999

  11. Spinu D, Rădulescu A, Bratu O, Checheriţă IA, et al. Giantcondyloma acuminatum-Buschke-Lowenstein disease - aliterature review. Chirurgia (Bucur) 2014; 109 (4): 445-450.

  12. Kombe AJ, Li B, Zahid A, Mengist HM, et al. Epidemiologyand Burden of Human Papillomavirus and Related Diseases,Molecular Pathogenesis, and Vaccine Evaluation. FrontPublic Health 2021; 8: 552028. https://doi.org/10.3389/fpubh.2020.552028

  13. Manlubatan S, Onglao M, Tampo M, Lopez M. Outcomesof surgical management of buschke-lowenstein tumor ina Philippine tertiary hospital. Ann Coloproctol 2022; 38(1): 82-87. https://doi.org/10.3393/ac.2020.00731.0104

  14. Cuenca C, Álvarez-Palencia C, Ojeda D, Martínez M, etal. Condiloma acuminado gigante (tumor de Buschke-Löwenstein). Prog Obstet Ginecol 2010; 53 (8): 315-319.

  15. Purzycka-Bohdan D, Nowicki RJ, Herms F, Casanova JL, etal. The Pathogenesis of Giant Condyloma Acuminatum(Buschke-Lowenstein Tumor): An Overview. Int J Mol Sci2022; 23 (9): 45-47. https://doi.org/10.3390/ijms23094547

  16. Nieves-Condoy JF, Acuña-Pinzón CL, Chavarría-ChaviraJL, Hinojosa-Ugarte D, et al. Giant Condyloma Acuminata(Buschke-Lowenstein Tumor): Review of an Unusual Diseaseand Difficult to Manage. Infect Dis Obstet Gynecol 2021;2021: 9919446. https://doi.org/10.1155/2021/9919446

  17. Boda D, Cutoiu A, Bratu D, Bejinariu N, et al. Buschke-Löwenstein tumors: A series of 7 case reports. Exp Ther Med2022; 23 (6): 393. https://doi.org/10.3892/etm.2022.11320

  18. Akhavizadegan H. Electrocautery resection, shaving with ascalpel, and podophyllin: a combination therapy for giantcondyloma acuminatum. World J Mens Health 2015; 33(1): 39-41. https://doi.org/10.5534/wjmh.2015.33.1.39

  19. Badiu DC, Manea CA, Mandu M, Chiperi V, et al. GiantPerineal Condyloma Acuminatum (Buschke-LowensteinTumour): A Case Report. Chirurgia (Bucur) 2016; 111 (5):435-438. https://doi.org/10.21614/chirurgia.111.5.435

  20. Combaud V, Verhaeghe C, El Hachem H, Legendre G, etal. Giant condyloma acuminatum of the vulva: Successfulmanagement with imiquimod. JAAD Case Rep. 2018; 4(7): 692-694. https://doi.org/10.1016/j.jdcr.2018.04.007

  21. Geusau A, Heinz-Peer G, Volc-Platzer B, Stingl G, et al.Regression of deeply infiltrating giant condyloma (Buschke-Löwenstein tumor) following long-term intralesional interferonalfa therapy. Arch Dermatol 2000; 136 (6): 707-710.https://doi.org/10.1001/archderm.136.6.707

  22. Secretaria de salud. Actualización de esquema de vacunacióncontra Virus del Papiloma Humano (VPH) en niñas/adolescentes femeninas y en la población de mujerescis y trans que viven con VIH. 2022. https://www.gob.mx/cms/uploads/attachment/file/778784/NUEVO_ESQUEMA_VPH.pdf

  23. World Health Organization. One-dose Human Papillomavirus(HPV) vaccine offers solid protection againstcervical cancer. 2022. https://www.who.int/news/item/11-04-2022-one-dose-human-papillomavirus-(hpv)-vaccine-offers-solid-protection-against-cervical-cancer

  24. Giannone G, Giuliano AR, Bandini M, Marandino L, et al.HPV vaccination and HPV-related malignancies: impact,strategies and optimizations toward global immunizationcoverage. Cancer Treat Rev 2022; 111: 102467. https://doi.org/10.1016/j.ctrv.2022.102467

  25. Salmerón J, Torres-Ibarra L, Bosch FX, Cuzick J, et al. HPVvaccination impact on a cervical cancer screening program:methods of the FASTER-Tlalpan Study in Mexico. SaludPublica Mex 2016; 58 (2): 211-9. https://doi.org/10.21149/spm.v58i2.7790

  26. Bruni L, Serrano B, Bosch X, Castellsagué X. Vacuna frenteal virus del papiloma humano. Eficacia y seguridad [Humanpapillomavirus vaccine. Efficacy and safety]. EnfermInfecc Microbiol Clin 2015; 33 (5): 342-54. https://doi.org/10.1016/j.eimc.2015.03.018




2020     |     www.medigraphic.com